Poniard Pharmaceuticals Inc. said Monday its cancer drug candidate picoplatin did not help lung cancer patients live longer, sending its shares plunging in early trading.
Poniard cancer drug misses goal in lung cancerCourtesy Newsvine - business Mon, 11/16/2009 - 08:07
Poniard Pharmaceuticals Inc. said Monday its cancer drug candidate picoplatin did not help lung cancer patients live longer, sending its shares plunging in early trading. Related itemsUnusual 11 Mid-Day Movers 09/23: BNIVD, TSTR, ANTH,...
Analyst says new Levadex data could lift MAP stock
Morning Movers 02/07: (SATC) (BMTI) (CSTR) (MNI)...
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
Uniden TRU9496 2-Line Corded/Cordless Digital...
|
Popular by tags WeekMonth |
Post new comment